Free Trial

Fennec Pharmaceuticals (FENC) Insider Trading & Ownership

Fennec Pharmaceuticals logo
$8.28 +0.03 (+0.38%)
As of 12:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Fennec Pharmaceuticals (NASDAQ:FENC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.76%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$104.60K
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$506.97K
Get FENC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fennec Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FENC Insider Buying and Selling by Quarter

Fennec Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2025Rosty RaykovDirectorSell10,000$7.78$77,800.00  
5/19/2025Jeffrey S HackmanCEOBuy13,965$6.99$97,615.35  
5/16/2025Jeffrey S HackmanCEOBuy1,035$6.75$6,986.25  
5/5/2025Rosty RaykovDirectorSell10,000$6.31$63,100.00  
4/4/2025Rosty RaykovDirectorSell10,000$5.25$52,500.00  
3/5/2025Rosty RaykovDirectorSell10,000$6.79$67,900.00  
2/14/2025Chris A RallisDirectorSell1,186$6.82$8,088.52  
2/5/2025Rosty RaykovDirectorSell10,000$6.66$66,600.00  
1/6/2025Rosty RaykovDirectorSell10,000$6.08$60,800.00  
12/5/2024Rosty RaykovDirectorSell796$6.04$4,807.84  
12/2/2024Chris A RallisDirectorSell6,409$6.14$39,351.26  
11/4/2024Rosty RaykovDirectorSell2,431$4.31$10,477.61  
10/8/2024Chris A RallisDirectorSell1,406$4.53$6,369.18  
10/1/2024Rosty RaykovDirectorSell2,431$4.94$12,009.14  
8/1/2024Rosty RaykovCEOSell2,431$6.25$15,193.75  
7/5/2024Chris A RallisDirectorSell1,173$6.03$7,073.19  
7/2/2024Rosty RaykovCEOSell2,431$6.13$14,902.03  
(Data available from 1/1/2013 forward)

FENC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Fennec Pharmaceuticals includes Adrian Haigh, Chris A Rallis, Jeffrey S Hackman, Robert Andrade, and Rosty Raykov. Learn more on insiders at FENC.

11.76% of Fennec Pharmaceuticals stock is owned by insiders. Learn more on FENC's insider holdings.

The following insider purchased FENC shares in the last 24 months: Jeffrey S Hackman ($104,601.60).

Insiders have purchased a total of 15,000 FENC shares in the last 24 months for a total of $104,601.60 bought.

The following insiders have sold FENC shares in the last 24 months: Adrian Haigh ($863,778.46), Chris A Rallis ($189,302.64), Robert Andrade ($469,375.00), and Rosty Raykov ($1,634,959.10).

Insiders have sold a total of 348,753 Fennec Pharmaceuticals shares in the last 24 months for a total of $3,157,415.20 sold.

Fennec Pharmaceuticals Key Executives

  • Mr. Rostislav Raykov (Age 42)
    Pres, CEO & Director
  • Mr. Robert C. Andrade (Age 43)
    Chief Financial Officer
  • Mr. Mark Gowland
    Controller
  • Mr. Lei Fang
    Pres of Pharstat Inc
  • Ms. Anne McKay (Age 64)
    Regulatory Consultant


This page (NASDAQ:FENC) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners